期刊文献+

Cdk5与VEGF在糖尿病肾病小鼠肾小球足细胞中的表达及相关性研究 被引量:2

The relevant research about the expression of cylin-dependent kinase 5 and VEGF in the podocyte of mouse with diabetic nephropathy
下载PDF
导出
摘要 目的探讨周期素依赖性蛋白激酶5(Cdk5)和血管内皮生长因子(VEGF)在糖尿病肾病肾小球足细胞中的表达及相关性。方法选用db/db小鼠作为实验组(n=5),C57BL/6J小鼠作为对照组(n=5),2组小鼠在相同的饲养条件下,饲养至第14周并将其处死,取其肾脏,组织切片,采用免疫组化染色法测定Cdk5和VEGF表达并半定量分析。结果实验组、对照组小鼠Cdk5的表达均主要沿肾小球基底膜及足细胞分布,但实验组的表达强度高于对照组(实验组MOD值0.510±0.024,对照组MOD值0.486±0.023,P<0.05);对照组小鼠VEGF仅在足细胞有较弱表达(MOD值0.249±0.015 3),而实验组VEGF除了在肾小球足细胞阳性表达外,还可见系膜区阳性表达且表达强度明显增加(MOD值0.276±0.020),差异有统计学意义(P<0.05);Cdk5与VEGF表达的MOD值呈正相关(r=0.99)。结论 Cdk5和VEGF在糖尿病肾病肾小球足细胞中表达均增加,两者呈正相关关系,提示Cdk5和VEGF可能参与DN的发生发展。 Objective To discuss the expression and connection of Cdk5 and VEGF in the glomeruler podocytes of diabetic nephropathy. Methods In this study,selected db / db mice as experimental groups( n = 5),and C57 BL /6J mice as controls( n = 5). Both of them were feed under the same conditions and enviroment. They were sacrificed at 14 th week. Then the kidneys were dehydrated and embedded in paraffin,the tissue were sliced. The expressions of Cdk5 and VEGF were detected by immunohistochemical staining,and then data was analyzed. Results The expression of Cdk5 mainly distributed along the glomerular basement membrane and podocytes,whereas the expression intensity of Cdk5 in experimental mice was higher than that in the controls( the MOD value 0. 510 ± 0. 024 vs.0. 486 ± 0. 023,P 〈 0. 05); in the control group,VEGF mainly distributed in the glomerulus podocytes,however,in the DN group,VEGF distributed not only in the glomerulus podocytes,but also in mesangial area and its expression intensity is significantly increased comparing to the control group( the MOD value 0. 276 ± 0. 020 vs. 0. 249 ± 0. 015,P 〈 0. 05); The correlation analysis of Cdk5 and VEGF was positively correlated. Conclusion The expressions of Cdk5 and VEGF are increased in the glomerular podocytes of diabetic nephropathy,and both are positively correlated. It is suggested that Cdk5 and VEGF may be involved in the occurrence and development of DN process.
出处 《宁夏医学杂志》 CAS 2015年第3期203-205,I0001,共4页 Ningxia Medical Journal
基金 国家自然科学基金资助项目(NSFC81160093 NSFC81460161) 宁夏自然科学基金资助项目(NZ14160) 宁夏科技支撑资助项目(2013ZYS103) 宁夏科技攻关国际合作基金资助项目(2011ZYH169)
关键词 糖尿病肾病 足细胞 周期性依赖性蛋白激酶 血管内皮生长因子 Diabetic nephrology Podocytes Cdk5 VEGF
  • 相关文献

参考文献16

  • 1Brinkkoetter PT, Wu JS,Ohse T,et al. p35 the non - cyclin activa-tor of Cdk5 protects podocytes against apoptosis in vitro and in vivo[J]. Kidney International,2010,77(8) :690 -699.
  • 2毕逢辰,张彬,郑亚莉.Cdk5在肾小球足细胞中的表达及作用[J].宁夏医学杂志,2014,36(3):193-195. 被引量:3
  • 3Tufro A,Veron D. VEGF and podocytes in diabetic nephropathy[J]. Semin Nephrol,2012,32(4) :385 -393.
  • 4White KE, Bilous RW, Diabiopsies Study Group. Structural altera-tions to the podocyte are realated to proteinuria in type 2 diabeticpatients[ J] . Nephrol Dial Transplant,2004,19 (6) :1437 - 1440.
  • 5郑亚莉.糖尿病治疗前沿:细胞周期素依赖性蛋白激酶5(Cdk5)将成为治疗糖尿病的新靶点[J].宁夏医学杂志,2012,34(2):97-100. 被引量:1
  • 6Rosales JL,Lee KY. Extraneuronal roles of cyclin - dependent ki-nase 5[ J]. Bioessays,2006,28( 10) : 1023 - 1034.
  • 7Zhang Y,U H,Hao J,et al. High glucose increases Cdk5 activity inpodocytes via transforming growth factor - pi signaling pathway[J]. Exp Cell Res,2014,326(2) :219 -229.
  • 8Taniguchi YI,Pippin JW,Hagmann H,et al. Both cyclin I and p35are required for maximal survival benefit of cyclin - dependent ki-nase 5 in kidney podocytes [ J ]. Am J Physiol Renal Physiol ,2012,302(9) :1161 -1171.
  • 9Advani A. Vascular endothelial growth factor and the kidney :some-thing of the marvelous [ J ]. Curr Opin Nephrol Hypertens, 2014,23(1):87 -92.
  • 10Cha DR,Kang YS,Han SY,et al. Vascular endothelial growth fac-tor is increased during early stage of diabetic nephropathy in typeII diabetic rats[ J] . J Endocrinol,2004,183(1) : 183 - 194.

二级参考文献43

  • 1Zheng YL.A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons[J].Embo J,2005,24(1):209-220.
  • 2Zheng YL.A 24-residue peptide (p5),derived from p35,the Cdk5 neuronal activator,specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation[J].J Biol Chem,2010,285(44):34202-34212.
  • 3Wei FY.Cdk5-dependent regulation of glucose-stimulated insulin secretion[J].Nat Med,2005,11(10):1104-1108.
  • 4Ubeda M,Rukstalis JM,Habener JF.Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity[J].J Biol Chem,2006,281(39):28858-28864.
  • 5Zukerberg LR.Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation,kinase upregulation,and neurite outgrowth[J].Neuron,2000,26(3):633-646.
  • 6Matsuura I,Wang JH.Demonstration of cyclin-dependent kinase inhibitory serine/threonine kinase in bovine thymus[J].J Biol Chem,1996,271(10):5443-5450.
  • 7Dhavan R,Tsai LH.A decade of Cdk5[J].Nat Rev Mol Cell Biol,2001,2(10):749-759.
  • 8Patrick GN.Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration[J].Nature,1999,402(6762):615-622.
  • 9Kim D.Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity[J].Neuron,2008,60(5):803-817.
  • 10Ikiz B,Przedborski S.A sequel to the tale of p25/Cdk5 in neurodegeneration[J].Neuron,2008,60(5):731-732.

共引文献2

同被引文献42

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部